Correlation Between Transcode Therapeutics and Avenue Therapeutics
Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and Avenue Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and Avenue Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Transcode Therapeutics and Avenue Therapeutics, you can compare the effects of market volatilities on Transcode Therapeutics and Avenue Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of Avenue Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and Avenue Therapeutics.
Diversification Opportunities for Transcode Therapeutics and Avenue Therapeutics
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Transcode and Avenue is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and Avenue Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avenue Therapeutics and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with Avenue Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avenue Therapeutics has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and Avenue Therapeutics go up and down completely randomly.
Pair Corralation between Transcode Therapeutics and Avenue Therapeutics
Given the investment horizon of 90 days Transcode Therapeutics is expected to generate 2.37 times more return on investment than Avenue Therapeutics. However, Transcode Therapeutics is 2.37 times more volatile than Avenue Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Avenue Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 217,800 in Transcode Therapeutics on December 5, 2024 and sell it today you would lose (217,613) from holding Transcode Therapeutics or give up 99.91% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Transcode Therapeutics vs. Avenue Therapeutics
Performance |
Timeline |
Transcode Therapeutics |
Avenue Therapeutics |
Transcode Therapeutics and Avenue Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Transcode Therapeutics and Avenue Therapeutics
The main advantage of trading using opposite Transcode Therapeutics and Avenue Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, Avenue Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avenue Therapeutics will offset losses from the drop in Avenue Therapeutics' long position.Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Avenue Therapeutics vs. Hoth Therapeutics | Avenue Therapeutics vs. Revelation Biosciences | Avenue Therapeutics vs. Virax Biolabs Group | Avenue Therapeutics vs. Palisade Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |